TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharmaq AS
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,929,475
|
2,130,404
|
1,639,976 |
| Financial expenses |
54,946
|
13,824
|
84,593 |
| Earnings before taxes |
1,190,117
|
1,363,270
|
816,837 |
| Total assets |
4,841,562
|
3,943,884
|
2,997,071 |
| Current assets |
4,455,416
|
3,533,623
|
2,548,868 |
| Current liabilities |
469,458
|
459,621
|
412,904 |
| Equity capital |
4,330,281
|
3,476,225
|
2,583,233 |
| - share capital |
16,646
|
16,946
|
18,149 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
89.4%
|
88.1%
|
86.2% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
61.7%
|
64.0%
|
49.8% |
| Return on assets (ROA) |
25.7%
|
34.9%
|
30.1% |
| Current ratio |
949.1%
|
768.8%
|
617.3% |
| Return on equity (ROE) |
27.5%
|
39.2%
|
31.6% |
| Change turnover |
-163,196
|
599,086
|
345,557 |
| Change turnover % |
-8%
|
39%
|
27% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.